Feasibility Study of A VoRo UrologIc ScaffolD (ARID)
The objective of this study is to evaluate the safety and performance of the Voro Urologic Scaffold as a prophylactic treatment for post-prostatectomy stress urinary incontinence.

The study is a prospective, multicenter, single arm study. Up to 40 subjects will be treated at up to 3 investigational sites in Panama. Subjects will be followed up post-treatment at catheter removal, 6 weeks post prostatectomy, 3 months, 6 months, 12 months and 2 years.
- EligibilityCriteria: Inclusion Criteria:  Male 45-70 years of age Diagnosed with prostate cancer and scheduled for radical prostatectomy Gleason Grade Group 3 or lower Prostate size less than 80 grams Able and willing to provide written consent to participate in the study Able and willing to comply with study follow-up visits and procedures  Exclusion Criteria:  Malignant tumors outside of the prostate capsule confirmed via baseline assessments (e.g., mpMRI, bone scan) History of urinary incontinence, including stress or urge urinary incontinence On medications to treat overactive bladder (OAB) Post void residual >200 ml or > 25% voiding volume Presence of urethral stricture or bladder neck contracture Current or chronic urinary tract infection Prior urologic outlet surgical or minimally invasive procedure (e.g., TURP, HoLEP, Rezum, etc.). Prior pelvic radiation or anticipated need for radiation after radical prostatectomy Presence of stones in the bladder History of neurogenic bladder, sphincter abnormalities, or poor detrusor muscle function Body mass index >35 Insulin-dependent diabetes mellitus Current uncontrolled diabetes (i.e., hemoglobin A1c ≥7.5%) Intravesical prostatic protrusion (IPP) >5mm History of immunosuppressive conditions (e.g., AIDS, post-transplant) Any significant medical history that would pose an unreasonable risk or make the subject unsuitable for the study per investigator discretion Any cognitive or psychiatric condition that interferes with or precludes direct and accurate communication with the study investigator regarding the study or affect the ability to complete the study quality of life questionnaires Subject currently participating in other investigational studies unless approved by the Sponsor in writing - HealthyVolunteers: No - Gender: Male - MinimumAge: 45 Years - MaximumAge: 70 Years - StdAgeList: Adult, Older Adult